Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation in Esophageal Cancer
NCT01787006Phase 2Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Sep 2011
- Primary completion
- Sep 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in esophageal cancer, sponsored by Universitätsklinikum Schleswig-Holstein. Started Sep 2011; status: completed.
02
Drugs
KL-140
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01787006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787006.